[1] |
Schwarz RE, Smith DD. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database[J]. Ann Surg Oncol,2006,13(9): 1189-1200.
|
[2] |
Mizrahi JD, Surana R, Valle JW,et al. Pancreatic cancer[J]. Lancet,2020,395(10242): 2008-2020.
|
[3] |
Chari ST, Sharma A, Maitra A. Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects[J]. Ann Internal Med,2020,172(8): 558-559.
|
[4] |
Stacker SA, Williams SP, Karnezis T,et al. Lymphangiogenesis and lymphatic vessel remodelling in cancer[J]. Nat Rev Cancer,2014,14(3): 159-172.
|
[5] |
Schito L. Hypoxia-Dependent Angiogenesis and Lymphangiogenesis in Cancer[J]. Adv Exp Med Biol,2019,1136: 71-85.
|
[6] |
Wigerup C, Pahlman S, Bexell D. Therapeutic targeting of hypoxia and hypoxia-inducible factors in Cancer[J]. Pharmacol Ther,2016,164: 152-169.
|
[7] |
Jun JC, Rathore A, Younas H,et al. Hypoxia-inducible factors and cancer[J]. Curr Sleep Med Rep,2017,3(1): 1-10.
|
[8] |
Koong AC, Mehta VK, Le QT,et al. Pancreatic tumors show high levels of hypoxia[J]. Int J Radiat Oncol Biol Phys,2000,48(4): 919-922.
|
[9] |
Dauer P, Nomura A, Saluja A,et al. Microenvironment in determining chemo-resistance in pancreatic cancer: neighborhood matters. Pancreatology[J]. Pancreatology,2017,17(1): 7-12.
|
[10] |
Jin X, Dai L, Ma Y,et al. Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer[J]. Cancer Cell Int,2020,20: 273.
|
[11] |
Ni X, Zhao Y, Ma J,et al. Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer patients[J]. J Biomed Res,2013,27(6): 478-485.
|
[12] |
Zhang G, Cai J. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis[J]. J BUON,2019,24(6): 2553-2559.
|
[13] |
Ran S, Volk L, Hall K,et al. Lymphangiogenesis and lymphatic metastasis in breast cancer[J]. Pathophysiology,2010,17(4): 229-251.
|
[14] |
Liu M, Zhong J, Zeng Z,et al. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein[J]. Theranostics,2019,9(16): 4795-4810.
|
[15] |
Flockhart RJ, Webster DE, Qu K,et al. BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration[J]. Genome Res,2012,22(6): 1006-1014.
|
[16] |
Fang S, Liu Z, Guo Q,et al. High BANCR expression is associated with worse prognosis in human malignant carcinomas: an updated systematic review and meta-analysis[J]. BMC cancer,2020,20(1): 870.
|
[17] |
Fan Y-H, Ye M-H, Wu L,et al. BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: a meta-analysis[J]. Oncotarget,2017,8(4): 6295-6303.
|
[18] |
Shen X, Bai Y, Luo B,et al. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer[J]. Bio Res,2017,50(1): 32.
|
[19] |
Zhou T, Gao Y. Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma[J]. World J Surg Oncol,2016,14(1): 8.
|
[20] |
Liu ZH, Yang TX, Xu ZP,et al. Long non-coding RNA BANCR expression in esophageal squamous cell carcinoma and its effects on cell growth and invasion[J]. Progress in Modern Biomedicine,2016,16(24): 4622-4627.
|
[21] |
Lou KX, Li ZH, Wang P,et al. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion[J]. Eur Rev Med Pharmacol Sci,2018,22(5): 1358-1365.
|
[22] |
Zheng H, Xu J, Hao S,et al. Expression of BANCR promotes papillary thyroid cancer by targeting thyroid stimulating hormone receptor[J]. Oncol Lett,2018,16(2): 2009-2015.
|
[23] |
Sipos B, Kojima M, Tiemann K,et al. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis[J]. J Pathol,2005,207(3): 301-312.
|
[24] |
Cheng P, Jin G, Hu X,et al. Analysis of tumor-induced lymphangiogenesis and lymphatic vessel invasion of pancreatic carcinoma in the peripheral nerve plexus[J]. Cancer Sci,2012,103(10): 1756-1763.
|